HK1245332A1 - 用於治療神經變性的細胞療法 - Google Patents

用於治療神經變性的細胞療法

Info

Publication number
HK1245332A1
HK1245332A1 HK18104956.4A HK18104956A HK1245332A1 HK 1245332 A1 HK1245332 A1 HK 1245332A1 HK 18104956 A HK18104956 A HK 18104956A HK 1245332 A1 HK1245332 A1 HK 1245332A1
Authority
HK
Hong Kong
Prior art keywords
neurodegeneration
treatment
cell therapy
therapy
cell
Prior art date
Application number
HK18104956.4A
Other languages
English (en)
Inventor
托馬斯‧N‧蔡斯
佐佐木經世
古賀三奈子
Original Assignee
Ｎｃ醫學研究公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ｎｃ醫學研究公司 filed Critical Ｎｃ醫學研究公司
Priority to HK18104956.4A priority Critical patent/HK1245332A1/zh
Publication of HK1245332A1 publication Critical patent/HK1245332A1/zh

Links

HK18104956.4A 2018-04-17 2018-04-17 用於治療神經變性的細胞療法 HK1245332A1 (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HK18104956.4A HK1245332A1 (zh) 2018-04-17 2018-04-17 用於治療神經變性的細胞療法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HK18104956.4A HK1245332A1 (zh) 2018-04-17 2018-04-17 用於治療神經變性的細胞療法

Publications (1)

Publication Number Publication Date
HK1245332A1 true HK1245332A1 (zh) 2018-08-24

Family

ID=71142871

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18104956.4A HK1245332A1 (zh) 2018-04-17 2018-04-17 用於治療神經變性的細胞療法

Country Status (1)

Country Link
HK (1) HK1245332A1 (zh)

Similar Documents

Publication Publication Date Title
HK1247129A1 (zh) 治療癌症的聯合療法
IL267795A (en) Combined treatment for cancer
HK1251475A1 (zh) 用於癌症治療的聯合療法
GB201804255D0 (en) Macrophage-based therapy
IL274837B1 (en) Combined treatment for cancer
ZA202206743B (en) Therapy for the treatment of cancer
IL283948A (en) Methods for treating depression
IL280337A (en) LAG-3 combination therapy for cancer treatment
IL281845A (en) Combined treatment for cancer
GB201900702D0 (en) Therapy
GB201819853D0 (en) Therapy
SG11202101819QA (en) Gene therapy for the treatment of galactosemia
IL266993A (en) Combined therapy for cancer treatment
IL286000A (en) Asketamine for the treatment of depression
IL284162A (en) Integrated healing for cancer treatment
ZA201901578B (en) Combinations including abx196 for the treatment of cancer
IL280726A (en) Treatment of B-cell malignancies
IL281997A (en) Combined treatment for the treatment of uveal melanoma
SG11202101671PA (en) Anti-lmp2 tcr-t cell therapy for the treatment of ebv-associated cancers
SG11202011434SA (en) Methods for the treatment of bladder cancer
GB201817385D0 (en) Therapy
HK1245659A1 (zh) 用於治療神經變性的細胞療法
HK1245332A1 (zh) 用於治療神經變性的細胞療法
HK1246145A1 (zh) 用於治療神經變性的細胞療法
IL253642A0 (en) Combined treatment for cancer